Sanofi Patient Connection is a comprehensive program designed to assist patients through three main types of support:
- Reimbursement Connection
- Patient Assistance Connection
- Resource Connection
Programs Offered
Therapies Offered
-
Adacel® (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine absorbed)
-
Apidra® (insulin glulisine [rDNA origin] injection
-
Auvi-Q® (epinephrine injection, USP)
-
Clolar® (clofarabine) Injection
-
Elitek® (rasburicase)
-
Eloxatin®
-
Imogam® Rabies-HT Immune Globulin, [Human] USP, Heat Treated
-
Imovax® Rabies Vaccine [Human Diploid Cell]
-
Jevtana® (cabazitaxel) Injection
-
Lantus® (insulin glargine [rDNA origin] injection)
-
Leukine® (sargramostim)
-
Lovenox® (enoxaparin sodium injection)
-
Menactra® Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
-
Menomune® (Meningococcal Polysaccharide Vaccines Groups A, C, Y and W-135 combined)
-
Mozobil® (plerixafor injection)
-
Multaq® (dronedarone) Tablets
-
Priftin® (rifapentine) Tablets
-
Synvisc
-
Synvisc One
-
Tenivac® (tetanus and diphtheria toxoids adsorbed)
-
TheraCys® (BCG Live [Intravesical])
-
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]
-
Toujeo® (insulin glargine [rDNA origin] injection, 300 units/mL)
-
Zaltrap® (ziv-aflibercept)
The information provided on this page was provided by Sanofi and the Sanofi Foundation for North America. For information about specific prescription drugs, including the FDA-approved prescribing information, please visit www.sanofi.us.